Total Payments
$487.88
2017 Payments
$487.88
Companies
11
Transactions
36
Medicare Patients
3,223
Medicare Billing
$332,140
Payment Breakdown by Category
Food & Beverage$481.86 (98.8%)
Education$6.02 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $481.86 | 35 | 98.8% |
| Education | $6.02 | 1 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $147.28 | 13 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $127.13 | 7 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $58.86 | 5 | $0 (2017) |
| Lilly USA, LLC | $32.24 | 2 | $0 (2017) |
| GlaxoSmithKline, LLC. | $27.93 | 2 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $23.60 | 2 | $0 (2017) |
| Amgen Inc. | $20.26 | 1 | $0 (2017) |
| SANOFI PASTEUR INC. | $16.19 | 1 | $0 (2017) |
| Allergan Inc. | $12.44 | 1 | $0 (2017) |
| Novo Nordisk Inc | $11.14 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2017 | $487.88 | 36 | Janssen Pharmaceuticals, Inc ($147.28) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/11/2017 | Janssen Pharmaceuticals, Inc | — | Education | In-kind items and services | $6.02 | General |
| 08/25/2017 | Mylan Specialty L.P. | Dymista (Drug) | Food and Beverage | In-kind items and services | $10.81 | General |
| Category: Respiratory and Allergy | ||||||
| 08/17/2017 | Amgen Inc. | Prolia (Biological) | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Endocrinology | ||||||
| 08/16/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug), XARELTO | Food and Beverage | In-kind items and services | $16.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/02/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: DIABETES | ||||||
| 07/20/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $13.04 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/20/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $3.96 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 06/28/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA (Drug) | Food and Beverage | In-kind items and services | $11.70 | General |
| Category: RESPIRATORY | ||||||
| 06/08/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $5.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/24/2017 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), TRADJENTA | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: DIABETES | ||||||
| 05/10/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: RESPIRATORY | ||||||
| 04/29/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $41.22 | General |
| Category: Respiratory | ||||||
| 04/26/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $12.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 04/13/2017 | Lilly USA, LLC | TRULICITY (Drug), BASAGLAR | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Diabetes | ||||||
| 04/11/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $10.77 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/05/2017 | SANOFI PASTEUR INC. | MENACTRA (Drug), PENTACEL, FLUZONE HIGH-DOSE | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: VACCINES | ||||||
| 03/29/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/23/2017 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, ZOSTAVAX | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: ENDOCRINOLOGY | ||||||
| 03/20/2017 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $23.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 03/20/2017 | GlaxoSmithKline, LLC. | ANORO (Drug) | Food and Beverage | In-kind items and services | $10.88 | General |
| Category: RESPIRATORY | ||||||
| 03/08/2017 | Novo Nordisk Inc | Victoza (Drug), Tresiba | Food and Beverage | In-kind items and services | $11.14 | General |
| Category: Diabetes | ||||||
| 03/07/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/02/2017 | AstraZeneca Pharmaceuticals LP | BEVESPI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $11.78 | General |
| Category: Respiratory | ||||||
| 02/20/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug), BEVESPI AEROSPHERE | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/20/2017 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $10.40 | General |
| Category: Cardiovascular and Metabolism | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 10 | 637 | 868 | $153,681 | $65,801 |
| 2021 | 14 | 1,253 | 1,772 | $289,020 | $138,411 |
| 2020 | 19 | 1,333 | 1,832 | $294,089 | $127,927 |
Total Patients
3,223
Total Services
4,472
Medicare Billing
$332,140
Procedure Codes
43
All Medicare Procedures & Services
43 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 269 | 475 | $97,752 | $32,370 | 33.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 149 | 149 | $27,644 | $19,076 | 69.0% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 14 | 16 | $7,002 | $3,349 | 47.8% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2022 | 16 | 16 | $4,400 | $2,660 | 60.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 48 | 51 | $7,125 | $2,302 | 32.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2022 | 13 | 13 | $3,326 | $2,157 | 64.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 31 | 31 | $2,787 | $2,121 | 76.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 39 | 39 | $1,397 | $1,107 | 79.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 44 | 63 | $2,098 | $605.92 | 28.9% |
| 81002 | Urinalysis, manual test | Office | 2022 | 14 | 15 | $150.00 | $52.07 | 34.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 415 | 844 | $170,396 | $70,575 | 41.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 173 | 173 | $31,456 | $22,722 | 72.2% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2021 | 69 | 69 | $18,602 | $11,375 | 61.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 144 | 178 | $24,475 | $10,356 | 42.3% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 35 | 40 | $17,188 | $8,817 | 51.3% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 110 | 110 | $9,568 | $7,174 | 75.0% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2021 | 16 | 16 | $4,034 | $2,673 | 66.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 116 | 116 | $4,059 | $1,902 | 46.9% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 86 | 128 | $4,159 | $1,243 | 29.9% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 19 | 24 | $1,940 | $930.26 | 48.0% |
| G0009 | Administration of pneumococcal vaccine | Office | 2021 | 15 | 15 | $524.00 | $245.88 | 46.9% |
| 93000 | Routine ekg using at least 12 leads including interpretation and report | Office | 2021 | 20 | 21 | $1,801 | $234.40 | 13.0% |
| 81002 | Urinalysis, manual test | Office | 2021 | 22 | 25 | $250.00 | $87.00 | 34.8% |
| G0403 | Electrocardiogram, routine ecg with 12 leads; performed as a screening for the initial preventive physical examination with interpretation and report | Office | 2021 | 13 | 13 | $568.00 | $76.80 | 13.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 370 | 735 | $144,882 | $51,742 | 35.7% |
About Dr. Jane Garnjost, D.O
Dr. Jane Garnjost, D.O is a Internal Medicine healthcare provider based in Bath, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 02/01/2007. The National Provider Identifier (NPI) number assigned to this provider is 1174660617.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Jane Garnjost, D.O has received a total of $487.88 in payments from pharmaceutical and medical device companies, with $487.88 received in 2017. These payments were reported across 36 transactions from 11 companies. The most common payment nature is "Food and Beverage" ($481.86).
As a Medicare-enrolled provider, Garnjost has provided services to 3,223 Medicare beneficiaries, totaling 4,472 services with total Medicare billing of $332,140. Data is available for 3 years (2020–2022), covering 43 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Bath, PA
- Active Since 02/01/2007
- Last Updated 04/27/2012
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1174660617
Products in Payments
- INVOKANA (Drug) $95.69
- FARXIGA (Drug) $74.13
- BEVESPI AEROSPHERE (Drug) $53.00
- XARELTO (Drug) $45.57
- TRULICITY (Drug) $32.24
- ANORO (Drug) $27.93
- JANUVIA (Drug) $23.60
- SPIRIVA (Drug) $23.52
- JARDIANCE (Drug) $22.18
- Prolia (Biological) $20.26
- MENACTRA (Drug) $16.19
- TRADJENTA (Drug) $13.16
- BYSTOLIC (Drug) $12.44
- Victoza (Drug) $11.14
- Dymista (Drug) $10.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bath
Dr. Carol Holobinko, Do, DO
Internal Medicine — Payments: $2,443
Internal Medicine $2,443
Linda Blose, M.d, M.D
Internal Medicine — Payments: $2,436
Internal Medicine $2,436
Dr. Mohammad Mirza, M.d, M.D
Internal Medicine — Payments: $1,862
Internal Medicine $1,862
Iftikhar Ahmad, M.d, M.D
Internal Medicine — Payments: $439.09
Internal Medicine $439.09
Dr. Michelle Grosso, Md, MD
Internal Medicine — Payments: $289.36
Internal Medicine $289.36
Dr. Brent Nickischer, D.o, D.O
Internal Medicine — Payments: $224.40
Internal Medicine $224.40